Logo image of LCE.CA

CENTURY LITHIUM CORP (LCE.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:LCE - CA1566151066 - Common Stock

0.32 CAD
+0.01 (+3.23%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LCE. LCE was compared to 804 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for LCE as it has an excellent financial health rating, but there are worries on the profitability. LCE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year LCE has reported negative net income.
LCE had a negative operating cash flow in the past year.
In the past 5 years LCE always reported negative net income.
LCE had a negative operating cash flow in each of the past 5 years.
LCE.CA Yearly Net Income VS EBIT VS OCF VS FCFLCE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

LCE has a better Return On Assets (-4.34%) than 71.89% of its industry peers.
LCE's Return On Equity of -4.37% is fine compared to the rest of the industry. LCE outperforms 75.37% of its industry peers.
Industry RankSector Rank
ROA -4.34%
ROE -4.37%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LCE.CA Yearly ROA, ROE, ROICLCE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

LCE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LCE.CA Yearly Profit, Operating, Gross MarginsLCE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

There is no outstanding debt for LCE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LCE.CA Yearly Shares OutstandingLCE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
LCE.CA Yearly Total Debt VS Total AssetsLCE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

LCE has an Altman-Z score of 76.43. This indicates that LCE is financially healthy and has little risk of bankruptcy at the moment.
LCE has a better Altman-Z score (76.43) than 87.69% of its industry peers.
There is no outstanding debt for LCE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 76.43
ROIC/WACCN/A
WACCN/A
LCE.CA Yearly LT Debt VS Equity VS FCFLCE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 16.54 indicates that LCE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 16.54, LCE belongs to the top of the industry, outperforming 90.55% of the companies in the same industry.
A Quick Ratio of 16.54 indicates that LCE has no problem at all paying its short term obligations.
The Quick ratio of LCE (16.54) is better than 90.55% of its industry peers.
Industry RankSector Rank
Current Ratio 16.54
Quick Ratio 16.54
LCE.CA Yearly Current Assets VS Current LiabilitesLCE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.83% over the past year.
EPS 1Y (TTM)45.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.63%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

LCE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.33% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y57.08%
EPS Next 2Y25.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LCE.CA Yearly EPS VS EstimatesLCE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.01 -0.02 -0.03

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LCE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LCE.CA Price Earnings VS Forward Price EarningsLCE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LCE.CA Per share dataLCE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

LCE's earnings are expected to grow with 25.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.33%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LCE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CENTURY LITHIUM CORP

TSX-V:LCE (12/24/2025, 7:00:00 PM)

0.32

+0.01 (+3.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-23 2025-11-23/amc
Earnings (Next)03-25 2026-03-25/amc
Inst Owners0.01%
Inst Owner ChangeN/A
Ins Owners4.02%
Ins Owner ChangeN/A
Market Cap52.89M
Revenue(TTM)N/A
Net Income(TTM)-2.44M
Analysts84.44
Price Target1.94 (506.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)100%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.34
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.34%
ROE -4.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.54
Quick Ratio 16.54
Altman-Z 76.43
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.63%
EPS Next Y57.08%
EPS Next 2Y25.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.55%
OCF growth 3YN/A
OCF growth 5YN/A

CENTURY LITHIUM CORP / LCE.CA FAQ

Can you provide the ChartMill fundamental rating for CENTURY LITHIUM CORP?

ChartMill assigns a fundamental rating of 3 / 10 to LCE.CA.


Can you provide the valuation status for CENTURY LITHIUM CORP?

ChartMill assigns a valuation rating of 1 / 10 to CENTURY LITHIUM CORP (LCE.CA). This can be considered as Overvalued.


How profitable is CENTURY LITHIUM CORP (LCE.CA) stock?

CENTURY LITHIUM CORP (LCE.CA) has a profitability rating of 1 / 10.


How financially healthy is CENTURY LITHIUM CORP?

The financial health rating of CENTURY LITHIUM CORP (LCE.CA) is 8 / 10.